Skip to main content
Equibles
INSP logo

INSP · Inspire Medical Systems, Inc. · Metrics

Track INSP — free

Use INSP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INSP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$71.28 -0.07 (-0.09%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.06B
Shares
28.91M
Volume · Oct 21 44.98K Avg daily vol (3M) 799.53K

INSP metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$71.34
Market cap
$2.06B

Price action

20 metrics
Price change (1W)
+3.6%
Price change (30D)
-5.8%
Price change (3M)
+35.9%
Price change (6M)
+37.1%
Price change (YTD)
-22.6%
Price change (1Y)
-11.7%
Trailing year
Price change (5Y)
-71.6%
52-week high
$143.99
52-week low
$40.05
Change from 52-week high
-50.5%
Change from 52-week low
+78.1%
Annualized volatility
71.4%
Annualized volatility (3M)
64.3%
Beta
1.0
RSI (14D)
55.7
Price vs SMA 50
+7.0%
Price vs SMA 200
+19.8%
Avg volume (3M)
799,533
Relative volume
1.3
Average dollar volume
$51.94M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
28.91M

Valuation

12 metrics
P / E (TTM)
15.7
Trailing earnings · reciprocal yield 6.3%
PEG ratio
0.1
EV / revenue
1.9×
reciprocal yield 51.6%
EV / EBITDA
24.4×
reciprocal yield 4.1%
EV / EBIT
32.2×
reciprocal yield 3.1%
P / sales
2.3×
reciprocal yield 43.6%
P / book
2.5
reciprocal yield 40.0%
FCF yield
5.7%
TTM · current market cap
Buyback yield
4.8%
P / FCF
17.6
reciprocal yield 5.7%
P / operating cash flow
13.1
reciprocal yield 7.6%
Earnings yield
6.5%

Historical valuation

8 metrics
P / E historical average (3Y)
138.6×
reciprocal yield 0.7%
P / E historical average (5Y)
138.6×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.7%
EV / revenue historical average (5Y)
12.3×
reciprocal yield 8.1%
EV / EBIT historical average (3Y)
103.8×
reciprocal yield 1.0%
EV / EBIT historical average (5Y)
103.8×
reciprocal yield 1.0%
EV / EBITDA historical average (3Y)
80.5×
reciprocal yield 1.2%
EV / EBITDA historical average (5Y)
80.5×
reciprocal yield 1.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-10-06

Profitability

9 metrics
Gross margin
86.1%
Operating margin
6.0%
Trailing 12 months
Net margin
15.0%
Gross profit (TTM)
$774.11M
Operating profit (TTM)
$54.12M
Net income (TTM)
$135.04M
Trailing 12 months
Diluted EPS (TTM)
$4.53
FCF margin
13.0%
Effective tax rate
-94.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$30.73
Gross profit per diluted share (TTM)
$26.47
Operating profit per diluted share (TTM)
$1.83
EBITDA per diluted share (TTM)
$2.42
Net income per diluted share (TTM)
$4.55
Operating cash flow per diluted share (TTM)
$5.34
Free cash flow per diluted share (TTM)
$3.97
Capital expenditures per diluted share (TTM)
$1.37
R&D per diluted share (TTM)
$3.41
Stock compensation per diluted share (TTM)
$4.09
Book value per share
$27.33

Growth

11 metrics
Revenue growth YoY
-7.6%
Year over year
Net income growth YoY
+171.8%
Revenue (TTM)
$898.74M
Trailing 12 months
EPS growth YoY
+179.4%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+30.8%
Revenue CAGR (5Y)
+51.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+216.6%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
16.4%
Return on assets
14.6%
Debt / equity
0.0
Current ratio
8.6
EBITDA (TTM)
$71.35M
Free cash flow (TTM)
$117.09M
Quick ratio
6.2
Interest coverage
—
Net debt / EBITDA
-4.5
Return on invested capital
—
Trailing 12 months
Net cash
$320.68M
Latest balance sheet
Cash & equivalents
$127.76M
Total assets
$925.99M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$157.07M
Capital expenditures (TTM)
$39.98M
R&D (TTM)
$99.68M
SG&A (TTM)
$620.30M
Stock compensation (TTM)
$119.39M
R&D / revenue
11.1%
Stock compensation / revenue
13.3%

Ownership (13F)

9 metrics
13F filers
277
13F filer change QoQ
-27
Institutional ownership
128.8%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.8%
Holder tenure
12.9
Price vs estimated holder cost
-47.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
26.1%

Short interest

3 metrics
Short interest
14.5%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
79 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$57,347
Insider-sentiment score
54 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1609550 CUSIP 457730109 13F (30d) 35 filings 34 filers Visit website Investor relations